Task: Answer the multiple-choice question.
Question: Which compound exhibits a 4.422% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] COc1cc(NC(=O)C2CCC(CNS(=O)(=O)c3csc(C(N)=O)c3)CC2)cc(OC)c1
[b] COc1ccc(NC(=O)Nc2nnc(CC(=O)Nc3ccccc3)s2)cc1
Answer: b. COc1ccc(NC(=O)Nc2nnc(CC(=O)Nc3ccccc3)s2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)Nc2nnc(CC(=O)Nc3ccccc3)s2)cc1
COc1ccc(NC(=O)Nc2nnc(CC(=O)Nc3ccccc3)s2)cc1
2-[5-[(4-methoxyphenyl)carbamoylamino]-1,3,4-thiadiazol-2-yl]-N-phenylacetamide